T. F. Cloughesy

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Jennifer Clarke, M. M. Ennis, W. K. Alfred Yung et al. · Neuro-Oncology · 2011 · 118 citations · Full text

Medicine, Oncology, Surgery +17

18F-FDOPA and 18F-FLT positron emission tomography parametric response maps predict response in recurrent malignant gliomas treated with bevacizumab

Robert J. Harris, T. F. Cloughesy, Whitney B. Pope et al. · Neuro-Oncology · 2012 · 106 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

Monitoring Carotid Test Occlusions with Continuous EEG and Clinical Examination

T. F. Cloughesy, Marc R. Nuwer, Daniel B. Hoch et al. · Journal of Clinical Neurophysiology · 1993 · 63 citations

Life Sciences, Neurology, Neuroscience +14

A phase I trial of erlotinib in patients with nonprogressive glioblastoma multiforme postradiation therapy, and recurrent malignant gliomas and meningiomas

Jeffrey J. Raizer, L. E. Abrey, Andrew B. Lassman et al. · Neuro-Oncology · 2009 · 55 citations · Full text

Pharmacy, Oncology, Pharmacokinetics +17

Novel brainstern syndrome associated with prostate carcinoma

Robert W. Baloh, Sarah E. DeRossett, T. F. Cloughesy et al. · Neurology · 1993 · 40 citations

Medicine, Neurology, Neuroscience +15